medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2018, Number 1

<< Back Next >>

Ann Hepatol 2018; 17 (1)

Short- and Long-term Outcomes between Young and Older HCC Patients Exceeding The Milan Criteria after Hepatectomy

Shen J, Li C, Yan L, Li B, Xu M, Yang J, Wang W, Wen T

Language: Spanish
References: 39
Page: 134-143
PDF size: 183.08 Kb.


ABSTRACT

Aim. The objective of this study was to evaluate short- and long-term survival after surgical treatment between young and older hepatocellular carcinoma (HCC) patients beyond the Milan criteria. Material and methods. One hundred fifty-seven HCC patients (≤ 55 years old) were categorized into group A, and one hundred fifty-eight HCC patients (› 55 years old) were categorized into group B. Postoperative complications and overall survival were retrospectively analyzed. Results. Older HCC patients had a higher rate of delayed extubation after surgery and suffered more complications after surgery, especially major complications. Intraoperative blood transfusion, liver fibrosis/cirrhosis and delayed extubation were risk factors related to postoperative complications. Microvascular invasion (MVI), tumor diameter, postoperative alpha-fetoprotein and the presence of satellites were independent risk factors for long-term survival. Young patients had more advanced tumors. Overall survival rates at 1, 3 and 5-years were 78.1%, 45.1% and 27.4% for young patients, respectively, and 86.5%, 57.5% and 42.4% for older patients, respectively (p = 0.007). Conclusion. The category A group had poorer tumor characteristics and worse prognoses than the category B group.


REFERENCES

  1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA: A Cancer Journal for Clinicians 2015; 65: 87-108.

  2. Wang FS, Fan JG, Zhang Z, Gao B, Wang HY. The global burden of liver disease: the major impact of China. Hepatology 2014; 60: 2099-108.

  3. Xu X, Lu D, Ling Q, Wei X, Wu J, Zhou L, Yan S, et al. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria. Gut 2015.

  4. Hsu CY, Liu PH, Hsia CY, Lee YH, Nagaria TS, Lee RC, Lin HC, et al. Surgical Resection is Better than Transarterial Chemoembolization for Patients with Hepatocellular Carcinoma Beyond the Milan Criteria: A Prognostic Nomogram Study. Ann Surg Oncol 2015.

  5. Yin L, Li H, Li AJ, Lau WY, Pan ZY, Lai EC, Wu MC, et al. Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan Criteria: a RCT. J Hepatol 2014; 61: 82-8.

  6. Jianyong L, Lunan Y, Wentao W, Yong Z, Bo L, Tianfu W, Minqing X, et al. Barcelona clinic liver cancer stage B hepatocellular carcinoma: transarterial chemoembolization or hepatic resection? Medicine 2014; 93: e180.

  7. Oishi K, Itamoto T, Kohashi T, Matsugu Y, Nakahara H, Kitamoto M. Safety of hepatectomy for elderly patients with hepatocellular carcinoma. World Journal of Gastroenterology: WJG 2014; 20: 15028-36.

  8. Hirokawa F, Hayashi M, Miyamoto Y, Asakuma M, Shimizu T, Komeda K, Inoue Y, et al. Surgical outcomes and clinical characteristics of elderly patients undergoing curative hepatectomy for hepatocellular carcinoma. J Gastrointestinal Surg 2013; 17: 1929-37.

  9. Ferrero A, Vigano L, Polastri R, Ribero D, Lo Tesoriere R, Muratore A, Capussotti L. Hepatectomy as treatment of choice for hepatocellular carcinoma in elderly cirrhotic patients. World J Surg 2005; 29: 1101-5.

  10. Chang PE, Ong WC, Lui HF, Tan CK. Is the prognosis of young patients with hepatocellular carcinoma poorer than the prognosis of older patients? A comparative analysis of clinical characteristics, prognostic features, and survival outcome. J Gastroenterol 2008; 43: 881-8.

  11. Takeishi K, Shirabe K, Muto J, Toshima T, Taketomi A, Maehara Y. Clinicopathological features and outcomes of young patients with hepatocellular carcinoma after hepatectomy. World J Surg 2011; 35: 1063-71.

  12. Golfieri R, Bilbao JI, Carpanese L, Cianni R, Gasparini D, Ezziddin S, Paprottka PM, et al. Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma. J Hepatol 2013; 59: 753-61.

  13. Chen CH, Chang TT, Cheng KS, Su WW, Yang SS, Lin HH, Wu SS, et al. Do young hepatocellular carcinoma patients have worse prognosis? The paradox of age as a prognostic factor in the survival of hepatocellular carcinoma patients. Liv Int 2006; 26: 766-73.

  14. Cho SJ, Yoon JH, Hwang SS, Lee HS. Do young hepatocellular carcinoma patients with relatively good liver function have poorer outcomes than elderly patients? J Gastroenterol Hepatol 2007; 22: 1226-31.

  15. Yan H, Yang Y, Zhang L, Tang G, Wang Y, Xue G, Zhou W, et al. Characterization of the genotype and integration patterns of hepatitis B virus in early- and late-onset hepatocellular carcinoma. Hepatology 2015; 61: 1821-31.

  16. Ikeda K, Arase Y, Saitoh S, Kobayashi M, Someya T, Hosaka T, Akuta N, et al. Prediction model of hepatocarcinogenesis for patients with hepatitis C virus-related cirrhosis. Validation with internal and external cohorts. J Hepatol 2006; 44: 1089-97.

  17. Peng SY, Chen WJ, Lai PL, Jeng YM, Sheu JC, Hsu HC. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and betacatenin mutations. Int J Cancer 2004; 112: 44-50.

  18. Simons JP, Ng SC, Hill JS, Shah SA, Zhou Z, Tseng JF. Inhospital mortality from liver resection for hepatocellular carcinoma: a simple risk score. Cancer 2010; 116: 1733-8.

  19. Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibanes E, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 2009; 250: 187-96.

  20. Figueras J, Llado L, Ruiz D, Ramos E, Busquets J, Rafecas A, Torras J, et al. Complete versus selective portal triad clamping for minor liver resections: a prospective randomized trial. Ann Surg 2005; 241: 582-90

  21. Kim KS. Current status of hepatic surgery in Korea. KAMJE 2009; 15(Suppl. 6): S60-S64.

  22. Fan ST, Mau Lo C, Poon RT, Yeung C, Leung Liu C, Yuen WK, Ming Lam C, et al. Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20- year experience. Ann Surg 2011; 253: 745-58.

  23. Kooby DA, Stockman J, Ben-Porat L, Gonen M, Jarnagin WR, Dematteo RP, Tuorto S, et al. Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg 2003; 237: 860-9; discussion 9-70.

  24. Okano K, Hirao T, Unno M, Fujii T, Yoshitomi H, Suzuki S, Satoi S, et al. Postoperative infectious complications after pancreatic resection. Brit J Surg 2015; 102: 1551-60.

  25. Studer P, Räber G, Ott D, Candinas D, Schnüriger B. Risk factors for fatal outcome in surgical patients with postoperative aspiration pneumonia. Int J Surg 2016; 27: 21-5.

  26. Kaplan J, Sarnaik S, Gitlin J, Lusher J. Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions. Blood 1984; 64: 308-10.

  27. Wong JS, Wong GL, Chan AW, Wong VW, Cheung YS, Chong CN, Wong J, et al. Liver stiffness measurement by transient elastography as a predictor on posthepatectomy outcomes. Ann Surg 2013; 257: 922-8.

  28. Hayashi Y, Morisawa K, Klompas M, Jones M, Bandeshe H, Boots R, Lipman J, et al. Toward improved surveillance: the impact of ventilator-associated complications on length of stay and antibiotic use in patients in intensive care units. CID 2013; 56: 471-7.

  29. Bouadma L, Wolff M, Lucet J-C. Ventilator-associated pneumonia and its prevention. Curr Opin Infect Dis 2012; 25: 395-404.

  30. Murata F, Iwade M, Hidano G, Tsunoda C, Nagata O, Ozaki M. Recovery from propofol anesthesia is delayed in hepatectomy patients due to altered pharmacodynamics. JSA 2006; 55: 150-7.

  31. Ataseven B, du Bois A, Reinthaller A, Traut A, Heitz F, Aust S, Prader S, et al. Pre-operative serum albumin is associated with post-operative complication rate and overall survival in patients with epithelial ovarian cancer undergoing cytoreductive surgery. Gynecol Oncol 2015; 138: 560-5.

  32. Nanashima A, Abo T, Nonaka T, Fukuoka H, Hidaka S, Takeshita H, Ichikawa T, et al. Prognosis of patients with hepatocellular carcinoma after hepatic resection: are elderly patients suitable for surgery? J Surg Oncol 2011; 104: 284-91.

  33. Lee SH, Choi HC, Jeong SH, Lee KH, Chung JI, Park YS, Hwang JH, et al. Hepatocellular carcinoma in older adults: clinical features, treatments, and survival. J Am Geriatr Soc 2011; 59: 241-50.

  34. Lu Y, Zhu M, Li W, Lin B, Dong X, Chen Y, Xie X, et al. Alpha fetoprotein plays a critical role in promoting metastasis of hepatocellular carcinoma cells. J Cell Mol Med 2016; 20: 549-58.

  35. Lencioni R, Chen XP, Dagher L, Venook AP. Treatment of intermediate/ advanced hepatocellular carcinoma in the clinic: how can outcomes be improved? Oncologist 2010; 15(Suppl. 4): 42-52.

  36. Carr BI, Guerra V. Hepatocellular carcinoma extrahepatic metastasis in relation to tumor size and alkaline phosphatase levels. Oncology 2016; 90: 136-42.

  37. Roayaie S, Blume IN, Thung SN, Guido M, Fiel MI, Hiotis S, Labow DM, et al. A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology 2009; 137: 850-5.

  38. Sumie S, Kuromatsu R, Okuda K, Ando E, Takata A, Fukushima N, Watanabe Y, et al. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol 2008; 15: 1375-82.

  39. Huang J, Li BK, Chen GH, Li JQ, Zhang YQ, Li GH, Yuan YF. Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomy. J Gastrointestinal Surg 2009; 13: 1627-35.




2020     |     www.medigraphic.com